Literature DB >> 26327725

Trends and Differences Among Three New Indicators of HIV Infection Progression.

Qian An1, Ruiguang Song2, Angela Hernandez1, H Irene Hall1.   

Abstract

OBJECTIVE: This study proposes three indicators of, and assesses the disparities and trends in, the risk of HIV infection progression among people living with diagnosed HIV infection in the United States.
METHODS: Using data reported to national HIV surveillance through June 2012, we calculated the AIDS diagnosis hazard, HIV (including AIDS) death hazard, and AIDS death hazard for people living with diagnosed HIV infection for each calendar year from 1997 to 2010. We also calculated a stratified hazard in 2010 by age, race/ethnicity, mode of transmission, region of residence at diagnosis, and year of diagnosis.
RESULTS: The risk of HIV infection progression among people living with diagnosed HIV infection decreased significantly from 1997 to 2010. The risks of progression to AIDS and death in 2010 were higher among African Americans and people of multiple races, males exposed through injection drug use (IDU) or heterosexual contact, females exposed through IDU, people residing in the South at diagnosis, and people diagnosed in 2009 compared with white individuals, men who have sex with men, females with infection attributed to heterosexual contact, those residing in the Northeast, and those diagnosed in previous years, respectively. People aged 15-29 years had the highest AIDS diagnosis hazard in 2010.
CONCLUSION: Continued efforts are needed to ensure early HIV diagnosis as well as initial linkage to and continued engagement in HIV medical care among all people living with HIV. Targeted interventions are needed to improve health-care and supportive services for those with worse health outcomes.

Entities:  

Mesh:

Year:  2015        PMID: 26327725      PMCID: PMC4529831          DOI: 10.1177/003335491513000510

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  21 in total

1.  Racial/ethnic disparities in HIV diagnoses among persons aged 50 years and older in 37 US States, 2005-2008.

Authors:  Laurie Linley; Joseph Prejean; Qian An; Mi Chen; H Irene Hall
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

2.  Delayed access to HIV diagnosis and care: Special concerns for the Southern United States.

Authors:  Christopher S Krawczyk; Ellen Funkhouser; J Michael Kilby; Sten H Vermund
Journal:  AIDS Care       Date:  2006

3.  Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.

Authors:  R Andersen; S Bozzette; M Shapiro; P St Clair; S Morton; S Crystal; D Goldman; N Wenger; A Gifford; A Leibowitz; S Asch; S Berry; T Nakazono; K Heslin; W Cunningham
Journal:  Health Serv Res       Date:  2000-06       Impact factor: 3.402

4.  Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy.

Authors:  K E Poundstone; R E Chaisson; R D Moore
Journal:  AIDS       Date:  2001-06-15       Impact factor: 4.177

5.  Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.

Authors:  M F Shapiro; S C Morton; D F McCaffrey; J W Senterfitt; J A Fleishman; J F Perlman; L A Athey; J W Keesey; D P Goldman; S H Berry; S A Bozzette
Journal:  JAMA       Date:  1999 Jun 23-30       Impact factor: 56.272

6.  Late presentation for human immunodeficiency virus care in the United States and Canada.

Authors:  Keri N Althoff; Stephen J Gange; Marina B Klein; John T Brooks; Robert S Hogg; Ronald J Bosch; Michael A Horberg; Michael S Saag; Mari M Kitahata; Amy C Justice; Kelly A Gebo; Joseph J Eron; Sean B Rourke; M John Gill; Benigno Rodriguez; Timothy R Sterling; Liviana M Calzavara; Steven G Deeks; Jeffrey N Martin; Anita R Rachlis; Sonia Napravnik; Lisa P Jacobson; Gregory D Kirk; Ann C Collier; Constance A Benson; Michael J Silverberg; Margot Kushel; James J Goedert; Rosemary G McKaig; Stephen E Van Rompaey; Jinbing Zhang; Richard D Moore
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

7.  Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach.

Authors:  Kathleen McDavid Harrison; Tebitha Kajese; H Irene Hall; Ruiguang Song
Journal:  Public Health Rep       Date:  2008 Sep-Oct       Impact factor: 2.792

8.  Using the HIV surveillance system to monitor the National HIV/AIDS Strategy.

Authors:  Kristen Mahle Gray; Tian Tang; Luke Shouse; Jianmin Li; Jonathan Mermin; H Irene Hall
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

9.  County-level socioeconomic status and survival after HIV diagnosis, United States.

Authors:  Kathleen McDavid Harrison; Qiang Ling; Ruiguang Song; H Irene Hall
Journal:  Ann Epidemiol       Date:  2008-12       Impact factor: 3.797

10.  CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?

Authors:  Keri N Althoff; Kelly A Gebo; Stephen J Gange; Marina B Klein; John T Brooks; Robert S Hogg; Ronald J Bosch; Michael A Horberg; Michael S Saag; Mari M Kitahata; Joseph J Eron; Sonia Napravnik; Sean B Rourke; M John Gill; Benigno Rodriguez; Timothy R Sterling; Steven G Deeks; Jeffrey N Martin; Lisa P Jacobson; Gregory D Kirk; Ann C Collier; Constance A Benson; Michael J Silverberg; James J Goedert; Rosemary G McKaig; Jennifer Thorne; Anita Rachlis; Richard D Moore; Amy C Justice
Journal:  AIDS Res Ther       Date:  2010-12-15       Impact factor: 2.250

View more
  5 in total

Review 1.  Reducing rates of preventable HIV/AIDS-associated mortality among people living with HIV who inject drugs.

Authors:  Surita Parashar; Alexandra B Collins; Julio S G Montaner; Robert S Hogg; Michael-John Milloy
Journal:  Curr Opin HIV AIDS       Date:  2016-09       Impact factor: 4.283

2.  Trends and Disparities in Mortality and Progression to AIDS in the Highly Active Antiretroviral Therapy Era: Tennessee, 1996-2016.

Authors:  Peter F Rebeiro; April C Pettit; Lindsey Sizemore; Samantha A Mathieson; Carolyn Wester; Aaron Kipp; Bryan E Shepherd; Timothy R Sterling
Journal:  Am J Public Health       Date:  2019-07-18       Impact factor: 9.308

Review 3.  The Opioid Epidemic: Impact on Inflammation and Cardiovascular Disease Risk in HIV.

Authors:  Corrilynn O Hileman; Grace A McComsey
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.495

4.  Impact of Heroin and HIV on Gut Integrity and Immune Activation.

Authors:  Corrilynn O Hileman; Emily R Bowman; Janelle Gabriel; Aaren Kettelhut; Danielle Labbato; Cheryl Smith; Ann Avery; Theodore Parran; Nicholas Funderburg; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-15       Impact factor: 3.771

5.  The factors associated with natural disease progression from HIV to AIDS in the absence of ART, a propensity score matching analysis.

Authors:  X C Jia; Z H Xia; N Shi; Y P Wang; Z X Luo; Y L Yang; X Z Shi
Journal:  Epidemiol Infect       Date:  2020-02-24       Impact factor: 2.451

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.